Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sports Betting Casinos 2022 | 50 Sports Betting Casino Operators To Join In 2022

Sports Betting Casinos 2022 | 50 Sports Betting Casino Operators To Join In 2022Which UK Gambling Operators Are Offering Sports Betting & Casino In 2022?Our top recommendations for sports betting casinos are below and are all licensed and regulated by the UK Gambling Commission. 18+ Please gamble responsibly.1. Betway Sports Betting CasinoBetway is featured in our sports betting casinos and are regulated and licensed to operate sports betting and online casino in the UK.Visit Betway Sports Betting Casino Here 

#22-6 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Flowboxer of the month – December 2021: IKEA Spain

Christmas has just passed, but the festive season rang in a cheer for brands across the Flowbox community. Brands that developed a user generated content (UGC) campaign during this festive season benefitted the most, from digitally capturing their audience’s attention to running seasonal offers. Flowboxers put out holiday Flows on their websites, and Christmas advent calendars were rolled out. Many of these Christmas campaigns have us truly impressed, and as per usual, it’s time to name a winner for Flowboxer of the month – holiday edition.  Congratulations to IKEA Spain – the

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2021

Strong sales growth during 2021; Zinzino group revenue increased with a total of 15% in Q4 and 20% for the full year 2021, compared with the previous year.The revenue in December for Zinzino's sales markets increased by 6% to SEK 135.2 (127.3) million due to solid growth in several regions. Faun Pharma's external sales decreased by 38% and amounted to SEK 4.0 (6.5) million. Overall, the Group increased revenues by 4% to SEK 139.2 (133.8) million compared with the previous year. The fourth quarter of 2021 became a solid quarter; the Zinzino based revenue in October – December increased by

DNB Group: Basis swap and AT1 impact in Q4 2021

In the fourth quarter of 2021, the DNB Group will recognise a positive effect of NOK 100 million from basis swaps connected to funding. Furthermore, a positive effect of NOK 125 million from the USD Additional Tier 1 capital will also be recognised. For further information, please contact: Rune Helland, head of Investor Relations, tel. (+47) 23 26 84 00 / (+47) 977 13 250 This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act.

Towards smarter buildings – Caverion supports research at Aalto University in Finland

Caverion Corporation Press release 5 January 2022 at 11.30 a.m. EETTowards smarter buildings – Caverion supports research at Aalto University in Finland Aalto University receives a donation from Caverion for the development and education and research of smart building technology and smart buildings. Caverion is committed to financially support the Intelligent Buildings Doctoral school, part of School of Electrical Engineering, between 2021-2025. “We are happy to get Caverion, one of the leaders in its field, as one of our supporters for the next five years. Our Doctoral school trains

ChromoGenics presents at Digitala Aktiekvällen on January 12

ChromoGenics will be participating in Aktiespararna’s event ”Digitala Aktiekvällen” on January 12 2022. Fredrik Fränding, CEO, will do a company presentation followed by an QA at 18:00-18:30.We invite journalists, analysts and stakeholders to listen to the presentation online via www.aktiespararna.se/tv/live. The event is open to all and does not require membership of Aktiespararna. No registration is required to follow the event digitally. Take the opportunity to ask your questions to Fredrik Fränding, by sending a text to 079-347 98 45 or email to event@aktiespararna.se. Your questions

LeDap acquires Racketspecialisten – the leading eCommerce player for Padel and racket sports in Northern Europe

LeDap Group (“LeDap”) today announces the acquisition of Racketspecialisten (“RS”, www.racketspecialisten.se) and complements its leading position in Padel centres with an integrated eCommerce platform. Pontus Gustafsson, Group CEO of LeDap: “We are pleased to announce this important acquisition of RS. It allows LeDap to offer padel players in our core markets access to a complete and wide assortment of equipment, accessories and apparel. With an integrated approach between the eCommerce and in-centre stores, LeDap will further enhance the padel experience with a unique omni-channel

Notice of Extraordinary General Meeting of PostNord AB (publ)

Shareholders in PostNord AB (publ), reg. no. 556771-2640, are hereby invited to attend an Extraordinary General Meeting of the company. Time: Tuesday, February 1, 2022 at 09.00 CET Place: PostNord’s headquarters, Terminalvägen 24, Solna, SwedenImportant information regarding the COVID-19 pandemic  Because of the ongoing COVID-19 pandemic, the Board has decided that the General Meeting will not be open to the general public.   Right to participate and attend, and registration   Shareholders   Shareholders wishing to participate in the General Meeting must be entered in the

Taking high-dose vitamin D supplements for five years did not affect the incidence of cardiovascular disease or cancer

A trial by the University of Eastern Finland found that taking a much higher dose of vitamin D than recommended for five years did not affect total mortality or the incidence of cardiovascular disease or cancer in older men and women. In population studies, low levels of vitamin D in the body have been linked to an increased risk of many chronic diseases as well as premature death. However, it cannot be directly deduced from such observational studies whether the use of vitamin D supplementation can reduce the risk of disease or death. The early 2010s saw the commencement of large-scale

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 4 - 5 JANUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Atria Plc donates a total of EUR 65 000 to Finnish universities, Seinäjoki University of Applied Sciences and to Food and Forest Development Finland

Atria Plc will donate a total of EUR 60 000 to three Finnish universities and one university of applied sciences. In addition, Atria will donate EUR 5 000 to the Finnish Food and Forest Development Finland organisation to support agriculture and forestry in developing countries. The donations will go to: · Seinäjoki University of Applied Sciences EUR 20 000 · University of Vaasa EUR 20 000 · University of Eastern Finland EUR 10 000 · University of Tampere EUR 10 000 · FFD (Food and Forest Development Finland) EUR 5 000 – New innovations related to sustainable food

SKF licences slop-oil recovery technology to Christof Global Impact

Gothenburg, 5 January 2022: SKF has signed a license agreement that gives Christof Global Impact the exclusive rights to commercialise SKF’s multi-feedstock slop-oil recovery technology (MFRT). The MFRT was part of SKFs acquisition of RecondOil in 2019 and is not considered core to SKF’s current or future business. SKF retains its focus on developing the RecondOil Double Separation Technology (DST), which is used specifically for industrial lubricants and oils – in either offline or online systems. Thomas Fröst, President, SKF Industrial Technologies, says: “It’s great to have been

Greenfood is investing in eco-friendly banana boxes -100 percent recycled paper reduces climate emissions, saving 7,500 every year.

Greenfood attaches great importance to minimizing the environmental and climate footprint of its packaging. Therefore, Daily Green's banana boxes are now being replaced with a brand-new box made from 100 percent recycled paper. The new banana box reduces emissions of carbon dioxide equivalents by 308 kg per tonne of recycled paper, and no new wood raw material is used - in one year the new boxes save almost 7,000 trees. Greenfood is one of northern Europe's largest players in healthy and sustainable food; the group distributes fruit and vegetables and healthy convenience food throughout

Kamux moves to larger premises in Petikko, Vantaa

Kamux Corporation       Press release                 January 5, 2022 at 9:50 a.m. (EET) Kamux moves to larger premises in Petikko, Vantaa Kamux, a company specialising in used car sales, is relocating to larger premises in Petikko in Vantaa. "Petikko is a great location for a car dealership on Ring Road III, and now we are able to move to a larger showroom space in the same area. We are relocating to the Viisari shopping centre, which is located south of Ring Road III. The showroom space will also be more functional for us. We’ll start to do car sales in the location already in

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 4th January 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,853,005 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Norwegian insurance company Fremtind selects Cary Group as its supplier

Fremtind, Norway’s third-largest insurance company, has selected Cary Group’s Norwegian vehicle glass business, Cary Bilglass, as one of its strategic partners for vehicle glass repair. Fremtind operates on the Norwegian consumer market through its two brands Sparebank 1 and DNB.“We are very proud that Fremtind has chosen our Norwegian company Cary Bilglass to be one of their two strategic partners for insurance cases involving vehicle glass repair. One of the main reasons why Fremtind chose Cary Bilglass was the strong customer offering, which includes digital booking channels for

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Elicera Therapeutics strengthens IP protection for ELC-100 through acquisition of patent from Immunicum

Gothenburg, January 5, 2021 - Elicera Therapeutics AB (publ) (“Elicera”), a clinical stage cell and gene therapy company that develops next generation immuno-oncological treatments based on enhanced oncolytic viruses and CAR T-cells, today announced that it has acquired patent US 9,017,672 B2 – a viral vector used in its candidate ELC-100 – from Immunicum. The transfer of the patent amounts to a total of 250,000 EUR in payments, excluding potential milestones. The acquisition further strengthens the IP protection of ELC-100, Elicera’s most advanced project.The patent for the viral vector

Faron to Present at the H.C. Wainwright BioConnect Virtual Conference

Faron Pharmaceuticals Ltd (“Faron”)   Faron to Present at the H.C. Wainwright BioConnect Virtual Conference   Press Release, January 5, 2022 at 02:00 AM (EDT) / 07:00 AM (GMT) / 09:00 AM (EET)   TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron, will present at the H.C. Wainwright

Oncopeptides announces year-end cash 2021

STOCKHOLM — January 5, 2022 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces a financial update after the restructuring of the company, following the withdrawal of Pepaxto[® ](INN melphalan flufenamide) from the US market.The cash position at year-end 2021 was approximately SEK 360 M. This figure is preliminary, and the formal reporting of the cash position will be part of the year-end report 2021, to be released on February 17, 2022. Oncopeptides has taken

Finnair Traffic Performance in December 2021

Finnair Plc                Investor News              5 January 2022 at 9:00 a.m. EET Clear improvement in passenger traffic figures, although the COVID-19 pandemic impact still visible in December; cargo continued to excel In December, Finnair carried 602,700 passengers, which was 551.4% more than in December 2020. The number of passengers in December 2021 was 23.8% more than in November 2021 (month-on-month figures are not fully comparable as there is one fewer day in November). The COVID-19 impact, including the strict travel restrictions imposed by several countries due to the

Transfer of rights to Eklira, Duaklir completed

5 January 2022 07:00 GMT Transfer of global rights for Eklira and Duaklir to Covis Pharma completed AstraZeneca has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group (Covis Pharma). Financial considerationsUnder the terms of the agreement, AstraZeneca received a payment of $270m from Covis Pharma. AstraZeneca will also receive payments in respect of certain ongoing development costs related to the medicines. The income arising from the upfront payment will be

There are no items matching the current filter
There are no more items matching the current filter
Back to top